Nucleic acids, proteins, and antibodies
AssigneeHuman Genome Sciences, Inc.
InventorsCraig A. Rosen, Steven M. Ruben, Steven C. Barash
Life of this patent
Estimating the term…
Loading patent…
AssigneeHuman Genome Sciences, Inc.
InventorsCraig A. Rosen, Steven M. Ruben, Steven C. Barash
Estimating the term…
The present invention relates to novel ovarian and/or breast related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as “ovarian and/or breast antigens,” and the use of such ovarian and/or breast antigens for detecting disorders of the ovaries and/or breast, particularly the presence of ovarian and/or breast cancer and ovarian and/or breast cancer metastases. More specifically, isolated ovarian and/or breast associated nucleic acid molecules are provided encoding novel ovarian and/or breast associated polypeptides. Novel ovarian and/or breast polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human ovarian and/or breast associated polynucleotides and/or polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the ovaries and/or breast, including ovarian and/or breast cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting the production and function of the polypeptides of the present invention.
An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence at least 95% identical to a sequence selected from the group consisting of:
An isolated polypeptide comprising an amino acid sequence at least 90% identical to a sequence selected from the group consisting of:
The gene corresponding to the cDNA sequence of SEQ ID NO:Y.
A method of identifying an activity in a biological assay, wherein the method comprises:
Dependencies are inferred from the claim text.